488 related articles for article (PubMed ID: 21172868)
1. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A.
Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A
J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868
[TBL] [Abstract][Full Text] [Related]
2. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model.
Nakajima K; Kanda T; Takaishi M; Shiga T; Miyoshi K; Nakajima H; Kamijima R; Tarutani M; Benson JM; Elloso MM; Gutshall LL; Naso MF; Iwakura Y; DiGiovanni J; Sano S
J Immunol; 2011 Apr; 186(7):4481-9. PubMed ID: 21346238
[TBL] [Abstract][Full Text] [Related]
4. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis.
Mabuchi T; Takekoshi T; Hwang ST
J Immunol; 2011 Nov; 187(10):5026-31. PubMed ID: 21984702
[TBL] [Abstract][Full Text] [Related]
5. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis.
Chan JR; Blumenschein W; Murphy E; Diveu C; Wiekowski M; Abbondanzo S; Lucian L; Geissler R; Brodie S; Kimball AB; Gorman DM; Smith K; de Waal Malefyt R; Kastelein RA; McClanahan TK; Bowman EP
J Exp Med; 2006 Nov; 203(12):2577-87. PubMed ID: 17074928
[TBL] [Abstract][Full Text] [Related]
6. IL-23-mediated epidermal hyperplasia is dependent on IL-6.
Lindroos J; Svensson L; Norsgaard H; Lovato P; Moller K; Hagedorn PH; Olsen GM; Labuda T
J Invest Dermatol; 2011 May; 131(5):1110-8. PubMed ID: 21289639
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W
Nature; 2007 Feb; 445(7128):648-51. PubMed ID: 17187052
[TBL] [Abstract][Full Text] [Related]
9. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
10. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
[TBL] [Abstract][Full Text] [Related]
11. Involvement of IL-17F via the induction of IL-6 in psoriasis.
Fujishima S; Watanabe H; Kawaguchi M; Suzuki T; Matsukura S; Homma T; Howell BG; Hizawa N; Mitsuya T; Huang SK; Iijima M
Arch Dermatol Res; 2010 Sep; 302(7):499-505. PubMed ID: 20148256
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-dominant psoriasis-like skin inflammation induced by epidermal-specific expression of Raf in mice.
Tarutani M; Imai Y; Yasuda K; Tsutsui H; Nakanishi K; Yamanishi K
J Dermatol Sci; 2010 Apr; 58(1):28-35. PubMed ID: 20188517
[TBL] [Abstract][Full Text] [Related]
13. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
14. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ
Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
16. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis.
Siegemund S; Schütze N; Schulz S; Wolk K; Nasilowska K; Straubinger RK; Sabat R; Alber G
Int Immunol; 2009 May; 21(5):555-65. PubMed ID: 19297659
[TBL] [Abstract][Full Text] [Related]
17. IL-1RL2 and its ligands contribute to the cytokine network in psoriasis.
Blumberg H; Dinh H; Dean C; Trueblood ES; Bailey K; Shows D; Bhagavathula N; Aslam MN; Varani J; Towne JE; Sims JE
J Immunol; 2010 Oct; 185(7):4354-62. PubMed ID: 20833839
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.
Okiyama N; Sugihara T; Iwakura Y; Yokozeki H; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Aug; 60(8):2505-12. PubMed ID: 19644888
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.
Baldeviano GC; Barin JG; Talor MV; Srinivasan S; Bedja D; Zheng D; Gabrielson K; Iwakura Y; Rose NR; Cihakova D
Circ Res; 2010 May; 106(10):1646-55. PubMed ID: 20378858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
